Literature DB >> 17182761

Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates.

Virginia Davids1, Willem Hanekom, Sebastian J Gelderbloem, Anthony Hawkridge, Gregory Hussey, Ronel Sheperd, Lesley Workman, Jorge Soler, Rose Ann Murray, Stanley R Ress, Gilla Kaplan.   

Abstract

In 10-week-old infants vaccinated at birth with Japanese Mycobacterium bovis BCG, the number of dermal needle penetrations correlated positively with frequency of proliferating CD4(+) T cells in whole blood following BCG stimulation for 6 days but did not correlate with secreted cytokine levels after 7 h or interferon CD4(+) T-cell frequency after 12 h of BCG stimulation.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17182761      PMCID： PMC1797790          DOI： 10.1128/CVI.00309-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  24 in total

1.  Disseminated Mycobacterium peregrinum infection in a child with complete interferon-gamma receptor-1 deficiency.

Authors:  Ewa Koscielniak; Tjitske de Boer; Stephanie Dupuis; Ludmila Naumann; Jean Laurent Casanova; Tom H M Ottenhoff
Journal:  Pediatr Infect Dis J       Date:  2003-04       Impact factor: 2.129

2.  Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity.

Authors:  Daniel F Hoft; Shewangizaw Worku; Beate Kampmann; Christopher C Whalen; Jerrold J Ellner; Christina S Hirsch; Robin B Brown; Rhonda Larkin; Qing Li; Hyun Yun; Richard F Silver
Journal:  J Infect Dis       Date:  2002-10-23       Impact factor: 5.226

3.  BCG vaccine. WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2004-01-23

4.  Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies.

Authors:  Gregory D Hussey; Marcia L V Watkins; Elizabeth A Goddard; Sean Gottschalk; Elizabeth J Hughes; Karen Iloni; Maurice A Kibel; Stanley R Ress
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.

Authors:  R Döffinger; S Dupuis; C Picard; C Fieschi; J Feinberg; G Barcenas-Morales; J-L Casanova
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

6.  Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis.

Authors:  A A Chackerian; T V Perera; S M Behar
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Authors:  Lihao Chen; Jun Wang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 8.  Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria.

Authors:  Tom H M Ottenhoff; Tjitske De Boer; Jaap T van Dissel; Frank A W Verreck
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

9.  Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.

Authors:  Carol Goter-Robinson; Steven C Derrick; Amy Li Yang; Bo Young Jeon; Sheldon L Morris
Journal:  Vaccine       Date:  2006-02-20       Impact factor: 3.641

10.  The expression of early resistance to an infection with Mycobacterium tuberculosis by old mice is dependent on IFN type II (IFN-gamma) but not IFN type I.

Authors:  Joanne Turner; Ian M Orme
Journal:  Mech Ageing Dev       Date:  2004-01       Impact factor: 5.432
View more
  6 in total

Review 1.  Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

Review 2.  The current state of tuberculosis vaccines.

Authors:  David A Hokey; Ann Ginsberg
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

3.  Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.

Authors:  Benjamin M N Kagina; Brian Abel; Mark Bowmaker; Thomas J Scriba; Sebastian Gelderbloem; Erica Smit; Mzwandile Erasmus; Nonhlanhla Nene; Gerhard Walzl; Gillian Black; Gregory D Hussey; Anneke C Hesseling; Willem A Hanekom
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

Review 4.  Application of radiation technology in vaccines development.

Authors:  Ho Seong Seo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

5.  Bacille Calmette-Guérin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants.

Authors:  Agano Kiravu; Sophia Osawe; Anna-Ursula Happel; Trishana Nundalall; Jerome Wendoh; Sophie Beer; Nobomi Dontsa; Olatogni Berenice Alinde; Sikiratu Mohammed; Pam Datong; D William Cameron; Kenneth Rosenthal; Alash'le Abimiku; Heather B Jaspan; Clive M Gray
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

6.  Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial.

Authors:  Anthony Hawkridge; Mark Hatherill; Francesca Little; Margaret Ann Goetz; Lew Barker; Hassan Mahomed; Jerald Sadoff; Willem Hanekom; Larry Geiter; Greg Hussey
Journal:  BMJ       Date:  2008-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.